Protein overexpression of c-MET has a significant impact on survival in patients with uterine cervical adenocarcinoma

被引：0
|
作者：
Lee, J. Y. [1 ]
Kim, W. Y. [1 ]
Shim, S. H. [1 ]
Park, J. H. [1 ]
So, K. A. [1 ]
Kim, T. J. [1 ]
Lee, S. J. [1 ]
Park, H. K. [1 ]
机构：
[1] Konkuk Univ, Sch Med, Seoul, South Korea
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.274
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
386
引用
收藏
页码：180 / 181
页数：2
相关论文
共 50 条
  • [21] Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy
    Kim, Wook Youn
    Seo, Shin Hee
    Shim, Seung-Hyuk
    Park, Jin Hee
    Park, Hyung Kyu
    So, Kyeong A.
    Kim, Tae Jin
    Lee, Sun Joo
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (05) : 745 - 752
  • [22] Prognostic impact of lymphovascular invasion and C-MET overexpression in resected stage IB NSCLC
    Kim, I. H.
    Kang, J. H.
    Hong, S. H.
    Lee, I. H.
    Park, J. K.
    Sung, S. H.
    Kim, S. J.
    Kim, Y. K.
    Lee, K. -Y.
    Kim, T. -J.
    Kim, Y. S.
    Han, D. H.
    Yoo, I. R.
    Kim, J. -O.
    ANNALS OF ONCOLOGY, 2015, 26 : 144 - 144
  • [23] Overexpression of gastrin and c-met protein involved in human gastric carcinomas and intestinal metaplasia
    Tang, ZB
    Zhao, M
    Jiafu, JF
    Yang, GB
    Hu, FL
    He, JS
    Shen, H
    Gao, Z
    Zhao, A
    Li, JY
    Lu, YY
    ONCOLOGY REPORTS, 2004, 11 (02) : 333 - 339
  • [24] METPRO: Evaluating prognostic value of c-Met protein overexpression and concurrent biomarker presence
    Le, X.
    Aggarwal, C.
    Simmons, A.
    Crawford, S. A.
    Ng, S.
    Chen, C.
    Karve, S.
    Stein, S.
    Woll, K.
    Ansell, P. J.
    Mistry, A.
    Bryant, D.
    Wistuba, I. I.
    ANNALS OF ONCOLOGY, 2024, 35 : S829 - S829
  • [25] c-Met overexpression as an independent prognostic biomarker and therapeutic target in patients with poor prognostic pancreatic adenocarcinoma following surgical resection
    Neuzillet, Cindy
    Cros, Jerome
    Tijeras-Raballand, Annemilai
    De Gramont, Armand
    Moroch, Julien
    De Mestier, Louis
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Bachet, Jean-Baptiste
    Cvitkovic, Esteban
    Raymond, Eric
    Hammel, Pascal
    Couvelard, Anne
    CANCER RESEARCH, 2015, 75
  • [26] The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
    Olmez, O. F.
    Cubukcu, E.
    Evrensel, T.
    Kurt, M.
    Avci, N.
    Tolunay, S.
    Bekar, A.
    Deligonul, A.
    Hartavi, M.
    Alkis, N.
    Manavoglu, O.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (02): : 173 - 177
  • [27] The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
    Olmez, O. F.
    Cubukcu, E.
    Evrensel, T.
    Kurt, M.
    Avci, N.
    Tolunay, S.
    Bekar, A.
    Deligonul, A.
    Hartavi, M.
    Alkis, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S793 - S793
  • [28] The immunohistochemical expression of c-Met is an independent predictor of survival in patients with glioblastoma multiforme
    O. F. Olmez
    E. Cubukcu
    T. Evrensel
    M. Kurt
    N. Avci
    S. Tolunay
    A. Bekar
    A. Deligonul
    M. Hartavi
    N. Alkis
    O. Manavoglu
    Clinical and Translational Oncology, 2014, 16 : 173 - 177
  • [29] c-MET EXPRESSION AS AN INDICATOR OF SURVIVAL OUTCOME IN PATIENTS WITH ORAL TONGUE CARCINOMA
    Kim, Chul-Ho
    Koh, Yoon Woo
    Han, Jae Ho
    Kim, Jae Wook
    Lee, Jin Seok
    Baek, Seung Jae
    Hwang, Hye Sook
    Choi, Eun Chang
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (12): : 1655 - 1664
  • [30] c-MET as a target for MET inhibitors in patients with poor prognostic pancreatic adenocarcinoma following completed surgical resection
    Neuzillet, Cindy
    Cros, Jerome
    Tijeras-Raballand, Annemilai
    Moroch, Julien
    de Mestier, Louis
    Baia, Maryse
    Bedossa, Pierre
    Paradis, Valerie
    Sauvanet, Alain
    Bachet, Jean-Baptiste
    Raymond, Eric
    Hammel, Pascal
    Couvelard, Anne
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
12345